×
Aktivieren Sie Javascript in Ihrem Browser, um unsere Webseite optimal zu nutzen.
INHBB Antikörper (C-Term)
INHBB
Reaktivität: Human, Maus
WB, IHC (p), EIA
Wirt: Kaninchen
Polyclonal
unconjugated
Produktdetails anti-INHBB Antikörper
(ausblenden)
Target
Alle INHBB Antikörper anzeigen
INHBB
(Inhibin, beta B (INHBB))
Bindungsspezifität
Alle Epitope für INHBB Antikörper
AA 376-404, C-Term
Reaktivität
Alle Reaktivitäten für INHBB Antikörper
Human, Maus
Wirt
Alle Wirte für INHBB Antikörper
Kaninchen
Klonalität
Alle Klonalitäten für INHBB Antikörper
Polyklonal
Konjugat
Alle Konjugate für INHBB Antikörper
Dieser INHBB Antikörper ist unkonjugiert
Applikation
Alle Applikationen für INHBB Antikörper
Western Blotting (WB), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p)), Enzyme Immunoassay (EIA)
Spezifität
This antibody recognizes Human and Mouse INHBB (C-term).
Produktmerkmale
Purified Ig fraction
Aufreinigung
Protein A column, followed by peptide affinity purification
Immunogen
KLH conjugated synthetic peptide between 376-404 amino acids from the C-terminal region of human INHBB
Isotyp
Ig Fraction
Top Product
Discover our top product INHBB Primärantikörper
Alternativen
(anzeigen)
Anwendungsinformationen
(ausblenden)
Applikationshinweise
Suggested dilutions: ELISA: 1/1000. Western Blot: 1/100-1/500. Immunohistochemistry on Paraffin Sections: 1/10-1/50. Other applications not tested. Optimal dilutions are dependent on conditions and should be determined by the user.
Beschränkungen
Nur für Forschungszwecke einsetzbar
Handhabung
(ausblenden)
Format
Liquid
Konzentration
0.25 mg/mL
Buffer
PBS containing 0.09 % (W/V) Sodium Azide as preservative
Konservierungsmittel
Sodium azide
Vorsichtsmaßnahmen
This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
Handhabung
Avoid repeated freezing and thawing.
Lagerung
4 °C/-20 °C
Informationen zur Lagerung
Store undiluted at 2-8 °C for one month or (in aliquots) at -20 °C for longer.
Referenzen für anti-INHBB Antikörper (ABIN952903)
(ausblenden)
Zhong, Pons, Poirier, Jiang, Liu, Sandusky, Shahda, Nakeeb, Schmidt, House, Ceppa, Zyromski, Liu, Jiang, Couch, Koniaris, Zimmers : "The systemic activin response to pancreatic cancer: implications for effective cancer cachexia therapy. " in: Journal of cachexia, sarcopenia and muscle , Vol. 10 , Issue 5 , pp. 1083-1101 , (2020 ) (PubMed ).
Details zu INHBB
(ausblenden)
Target
INHBB
(Inhibin, beta B (INHBB))
Andere Bezeichnung
Inhibin beta B Chain (INHBB) (INHBB Produkte )
Hintergrund
The inhibin beta B subunit joins the alpha subunit to form a pituitary FSH secretion inhibitor. Inhibin has been shown to regulate gonadal stromal cell proliferation negatively and to have tumour-suppressor activity. In addition, serum levels of inhibin have been shown to reflect the size of granulosa-cell tumors and can therefore be used as a marker for primary as well as recurrent disease. Because expression in gonadal and various extragonadal tissues may vary severalfold in a tissue-specific fashion, it is proposed that inhibin may be both a growth/differentiation factor and a hormone. Furthermore, the beta B subunit forms a homodimer, activin B, and also joins with the beta A subunit to form a heterodimer, activin AB, both of which stimulate FSH secretion.Synonyms: Activin B, Activin beta-B chain
Molekulargewicht
45122 Da
Gen-ID
3625
NCBI Accession
NP_002184
UniProt
P09529
Pathways
Peptide Hormone Metabolism , Hormone Activity , Negative Regulation of Hormone Secretion
Zuletzt angesehen
(ausblenden)